Efficacy and Safety of Lower-Sodium Oxybate in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adult Participants With Idiopathic Hypersomnia (2659)

Article de revue

Avec comité de lecture

Yves Dauvilliers, Isabelle Arnulf, Nancy Foldvary-Schaefer, Patricia Chandler, Rupa Parvataneni, Dan Chen, Franck Skobieranda et Richard K. Bogan

Neurology, Vol.96(15_supplement)

13/04/2021

Résumé

Abstract only

1 Consultations de la notice

Titre: Efficacy and Safety of Lower-Sodium Oxybate in a Phase 3, Placebo-Controlled, Double-Blind, Randomized Withdrawal Study in Adult Participants With Idiopathic Hypersomnia (2659)
Créateurs - sans rôle: Yves Dauvilliers - Sleep and Wake Disorders Centre, Department of Neurology, Gui de Chauliac Hospital, University of Montpellier
Isabelle Arnulf - Sleep Disorder Unit, Pitié-Salpêtrière Hospital and Sorbonne University
Nancy Foldvary-Schaefer - Cleveland Clinic Lerner College of Medicine
Patricia Chandler - Jazz Pharmaceuticals, Inc
Rupa Parvataneni - Jazz Pharmaceuticals, Inc
Dan Chen - Jazz Pharmaceuticals, Inc
Franck Skobieranda - Jazz Pharmaceuticals, Inc
Richard K. Bogan - University of South Carolina
Détails de publication: Neurology, Vol.96(15_supplement)
Identifiants: 99140188909311
Unité académique: Institut des Neurosciences de Montpellier - INM
Langue: English
Type de ressource: Journal article